Repotrectinib
Repotrectinib, sold under the brand name Augtyro, is an anti-cancer medication used for the treatment of non-small cell lung cancer. Reference standards of Repotrectinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Repotrectinib
[catalogue_number] => PA 18 1690000
[category_ids] => ,78,70,82,
[chemical_name] =>
[weight] => 355.37
[form] => C18H18FN5O2
[cas] => 1802220-02-5
[pslug] => 1802220-02-5-repotrectinib-api-standards-pa181690000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 18 1690000
Molecular Formula : C18H18FN5O2
Molecular Weight : 355.37